Expression of β-catenin in basal cell carcinoma

British Journal of Dermatology

Volumn 148, Issue 5, 2003, Pages 964-970

  El Bahrawy, M ^a   El Masry, N ^b   Alison, M ^a   Poulsom, R ^c   Fallowfield, M ^d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d Mid Essex Hospitals Trust   (United Kingdom)

Author keywords

catenin; Basal cell carcinoma; Immunocytochemistry

Indexed keywords

BETA CATENIN; CATENIN; UVOMORULIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL NUCLEUS; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNODETECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

BETA CATENIN; CARCINOMA, BASAL CELL; CYTOSKELETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; SKIN; SKIN NEOPLASMS; TRANS-ACTIVATORS;

EID: 0037863142     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05240.x     Document Type: Article

References (31)

1. Ko CB, Walton S, Keczkes K et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269-72.
2. The Royal College of Pathologists. Minimum dataset for the reporting of common skin cancers. In: Standards and Minimum Datasets for Reporting Cancers. London: Royal College of Pathologists. 2002: 5-10.
3. Sloane JP. The value of typing basal cell carcinomas in predicting recurrence after surgical excision. Br J Dermatol 1977; 96: 27-32.
4. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23: 1118-26.
5. Hendrix JDJ, Parlette H. Micronodular basal cell carcinoma. A deceptive histologic subtype with frequent clinically undetected tumor extension. Arch Dermatol 1996; 132: 295-8.
6. Lang PGJ, Maize JC. Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 1986; 14: 186-96.
7. Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998; 32: 393-8.
8. Lo JS, Snow SN, Reizner GT. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715-19.
9. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci 1993; 17: 155-8.
10. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci USA 1990; 87: 4246-50.
11. Hirano S, Kimoto N, Shimoyama Y et al. Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell 1992; 70: 293-301.
12. Kawanishi J, Kato J, Sasaki K et al. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 1995; 15: 1175-81.
13. Molenaar M, van de Wetering M, Oosterwegel M et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996; 86: 391-9.
14. Behrens J, Kries JP, Kuhl M et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-42.
15. He Tong C, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-10.
16. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
17. Crawford HC, Fingleton BM, Rudolph Owen LA et al. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999; 18: 2883-91.
18. Morin PJ, Sparks AB, Korinek V, Barker N et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-90.
19. Rubinfeld B, Robbins P, El-Gamil M et al. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997; 275: 1790-2.
20. Moreno-Bueno G, Gamallo C, Perez-Gallego L et al. Beta-catenin expression in pilomatrixomas. Relationship with beta-catenin gene mutations and comparison with beta-catenin expression in normal hair follicles. Br J Dermatol 2001; 145: 576-81.
21. Kajino Y, Yamaguchi A, Hashimoto N et al. Beta-catenin gene mutation in human hair follicle-related tumors. Pathol Int 2001; 51: 543-8.
22. Kooy AJ, Tank B, de Jong AA et al. Expression of E-cadherin, alpha- and beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma. Hum Pathol 1999; 30: 1328-35.
23. Yamazaki F, Aragane Y, Kawada A, Tezuka T. Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma. Br J Dermatol 2001; 145: 771-7.
24. Rippey JJ, Rippey E. Characteristics of incompletely excised basal cell carcinomas of the skin. Med J Australas 1997; 166: 581-3.
25. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982; 49: 533-7.
26. El-Bahrawy MA, Poulsom R, Jeffery R et al. The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum Pathol 2001; 32: 1216-24.
27. Xia X, Qian S, Soriano S et al. Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis. Proc Natl Acad Sci USA 2001; 98: 10863-8.
28. Silye R, Karayiannakis AJ, Syrigos KN et al. E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 1998; 186: 350-5.
29. Papadavid E, Pignatelli M, Zakynthinos S et al. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol 2002; 196: 154-62.
30. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 1999; 21: 410-13.
31. Sanders DS, Blessing K, Hassan GA et al. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol Pathol 1999; 52: 151-7.